Male Breast Cancer

We have extensive experience in diagnosing and managing male breast cancer, a rare condition. Our imaging specialists and pathologists, as well as surgical, radiation, and medical oncologists, collaborate to create an individualized treatment plan for you based on the type of breast cancer, the molecular features of the tumor tissue, and how advanced the cancer is. Our doctors are active in clinical trials for men with breast cancer, and you and your doctor can discuss whether enrolling in one is right for you.

Clinical Trials and Research Studies

Phase 5

A Multicenter Phase I/II Trial of Anastrozole Palbociclib Trastuzumab and Pertuzumab in HR-positive Her2-positive Metastatic Breast Cancer (ASPIRE)

Learn More

Phase 3

RT CHARM: PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATED POST MASTECTOMY RADIATION WITH BREAST RECONSTRUCTION (ALLIANCE A221505)

Learn More

Phase 3

Phase III Study of sacituzumab govitecan (IMMU-132) Versus Treatment of Physicians Choice (TPC) in Hormonal Receptor Positive (HR+) HER2 Negative Metastatic Breast Cancer (MBC) who have failed at least one prior line of chemotherapy (IMMU-132-09)

Learn More

Phase 2

Radiation Dermatitis: A phase 1 randomized double blinded placebo controlled study of the safety and efficacy of a caffeine-based antifibrosis cream in patients with breast cancer undergoing radiation therapy (ReDCoAT Study)

Learn More